TOTAL MAT 1,50,05, % Unit PTR (Rs.) MAT (Rs.) SKU wise Qualify. Size

Size: px
Start display at page:

Download "TOTAL MAT 1,50,05, % Unit PTR (Rs.) MAT (Rs.) SKU wise Qualify. Size"

Transcription

1 Computataion of Retail Price based on Feb., 2014 Data under Para 4 of DPCO 2013 Hyoscine Butyl Bromide 10mg + Paracetamol 325 mg of M/s Kemwell Biopharma Pvt. Ltd & M/s Boehringer Ingelheim Pvt. Ltd Number of Companies cosisting of Market Share of 1% & Above 2 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation 7.43 Number of s considered 2 Average PTR 3.72 Add : 16% Retailer Margin 0.60 Retail Price (without local taxes) 4.32 % Reduction with compared to Highest Price 11.22% S. Description TOTAL 1,50,05, % Unit PTR (Rs.) (Rs.) SKU wise Y=Yes N=No Minimumum Price (Rs.) 3.24 Maximum Price (Rs.) 4.19 Average of all considered (Rs.) 3.72 Retail Price (Rs.) 4.32 Considered 1 Buscogast Plus Tablet Dolokind Spas Mankind Pharma Ltd 325mg+10mg 10 Tablet % Y Belic 10/325mg Tablet 10 Belic Alchem Phytoceuticals Ltd 325mg+10mg 10 Tablet % Y

2 Computataion of Retail Price based on April, 2016 Data under Para 4 of DPCO 2013 CEFTRIAXONE 500mg+ SULBACTUM 250mg Injection of M/s Aristo Laboratories Pvt. Ltd./M/s Aristo Pharmaceuticals Pvt. Ltd. Number of Companies cosisting of Market Share of 1% & Above 12 Sum of value considered for price calculation (in Lakhs) 1, Sum of PTR per unit considered for price calculation Number of s considered 15 Average PTR Add : 16% Retailer Margin 9.59 Retail Price (without local taxes) % Reduction with compared to Highest Price 17.15% S. प क व रण Description TOTAL 16,48,13, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Retail Price (Rs.) Brandwise (ignoring O% ) Y=Yes N=No Unit (Rs.) Considered 1 XONE SB 500/250 MG INJECTION 1 ML XONE SB ALKEM LABORATORIES LTD. 500/250 MG 1 Each ,21, % 1.53% Y CEFPRA S 500/250 MG INJECTION 1 CEFPRA S AMPRA PHARMACEUTICALS 500/250 MG 1 Each ,10, % 0.19% N BIG TUM 500/250 MG INJECTION 5 ML BIG TUM BESTOCHEM FORMULATIONS (I) LTD 500/250 MG 1 Each ,28, % 2.14% Y MONOTAX SB 500/250 MG INJECTION 10 ML MONOTAX SB BIOCHEM PHARMACEUTICAL INDS 500/250 MG 1 Each ,45, % 1.73% Y TRAXOL S 500/250 MG INJECTION 10 ML TRAXOL S CACHET PHARMACEUTICALS PVT LTD 500/250 MG 1 Each ,69,93, % 22.45% Y ODICEF S 500/250 MG INJECTION 1 ODICEF S GALPHA LABORATORIES LTD 500/250 MG 1 Each ,06,61, % 12.54% Y MILIBACT 500/250 MG INJECTION 5 ML MILIBACT GLENMARK PHARMACEUTICALS LTD. 500/250 MG 1 Each ,20, % 5.11% Y CESAFE SM 500/250 MG INJECTION 1 ML CESAFE SM GUJARAT TERCE LABORATORIES LTD 500/250 MG 1 Each ,12, % 0.31% N KEFTRAGARD 500/250 MG INJECTION 10 ML KEFTRAGARD IPCA LABORATORIES PVT LTD. 500/250 MG 1 Each ,00, % 2.18% Y TRIXON S 500/250 MG INJECTION 5 ML TRIXON S LINCOLN PHARMACEUTICALS LTD 500/250 MG 1 Each ,30, % 4.14% Y ACCUZON PLUS 500/250 MG INJECTION 1 ACCUZON PLUS MACLEODS PHARMACEUTICALS PVT.LTD 500/250 MG 1 Each ,43, % 4.09% Y CEFRINE PLUS 500/250 MG INJECTION 1 CEFRINE PLUS MACLEODS PHARMACEUTICALS PVT.LTD 500/250 MG 1 Each ,31, % 5.98% Y CEFRINE PLUS 500/250 MG INJECTION 1 ML CEFRINE PLUS MACLEODS PHARMACEUTICALS PVT.LTD 500/250 MG 1 Each ,19, % 5.98% Y MACZONE PLUS 500/250 MG INJECTION 5 ML MACZONE PLUS MACLEODS PHARMACEUTICALS PVT.LTD 500/250 MG 1 Each ,74, % 5.75% Y OFRAMAX FORTE 500/250 MG INJECTION 1 OFRAMAX FORTE RANBAXY LABORATORIES LTD 500/250 MG 1 Each ,20,77, % 13.40% Y I TAX S 500/250 MG INJECTION 1 I TAX S SANJIVINI BIOTECH PRIVATE LIMITED 500/250 MG 1 Each ,61, % 0.16% N CEFERA S 500/250 MG INJECTION 10 ML CEFERA S SHREYA LIFE SCIENCES PVT. LTD 500/250 MG 1 Each ,12, % 0.07% N XTUM 500/250 MG INJECTION 10 ML XTUM SHREYA LIFE SCIENCES PVT. LTD 500/250 MG 1 Each ,47, % 4.40% Y ANCEF SB 500/250 MG INJECTION 1 ANCEF SB SHRINIVAS GUJARAT LABORATORIES PVT LTD 500/250 MG 1 Each ,11, % 0.73% N MONOBACT 500/250 MG INJECTION 5 ML MONOBACT ZUVENTUS HEALTHCARE LTD 500/250 MG 1 Each ,16,08, % 13.11% Y Rs. Per Vial Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price 69.50

3 S. Computataion of Retail Price based on April, 2016 Data under Para 4 of DPCO 2013 GEMCITABINE 1.4gm Vial of M/s Intas Pharmaceuticals Ltd. Number of Companies cosisting of Market Share of 1% & Above 3 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 3 Average PTR Add : 16% Retailer Margin Retail Price (without local taxes) % Reduction with compared to Highest Price 12.11% प क व रण Description TOTAL 10,09,76, % Unit PTR (Rs.) (Rs.) SKU wise Y=Yes N=No Minimumum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Retail Price (Rs.) Unit (Rs.) Considered 1 CELZAR 1400 MG INJECTION 1 CELZAR CELON LABS 1400 MG 1 Each 2, % N CITAFINE 1400 MG INJECTION 1 CITAFINE EMCURE PHARMACEUTICALS LTD 1400 MG 1 Each 5, % Y GEMITA 1400 MG INJECTION 1 GEMITA FRESENIUS KABI INDIA PVT LTD 1400 MG 1 Each 6, % Y GEMITRATE 1400 MG INJECTION 1 GEMITRATE TORRENT PHARMACEUTICALS LTD MG 1 Each 4, % Y ONCOGEM 1400 MG INJECTION 20 ML ONCOGEM CIPLA LTD MG 1 Each 8, % N Rs. Per Worked out Retail Price 6, Claimed Retail Price 7, Already notified Retail Price - Proposed Retail Price 6,362.52

4 S. Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 HUMAN CHORIONIC GONADOTROPIN 2000 IU Inj. of M/s Sanzyme (P) Ltd. / M/s Sandoz Pvt. Ltd. Number of Companies cosisting of Market Share of 1% & Above 8 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 15 Average PTR Add : 16% Retailer Margin Retail Price (without local taxes) % Reduction with compared to Highest Price 26.23% प क व रण Description TOTAL 15,27,14, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Retail Price (Rs.) ) Unit (Rs.) Considered 1 OVIGYN 2000 IU INJECTION 1 ML OVIGYN ALEMBIC LTD 2000 IU 1 Each Vial ,29, % 0.28% N HUCOG HP 2000 IU INJECTION 1 HUCOG HP BHARAT SERUMS & VACCINES LTD 2000 IU 1 Each Vial ,22,97, % 27.70% Y OVUNAL-SC 2000 IU INJECTION 2 ML OVUNAL-SC INTAS PHARMACEUTICALS LTD 2000 IU 1 Each Vial , % 0.02% N LUPI-HCG 2000 IU INJECTION 1 LUPI-HCG LUPIN LTD 2000 IU 1 Each Vial ,81,58, % 18.44% Y MY HCG 2000 IU INJECTION 1 MY HCG MYLAN 2000 IU 1 Each Vial ,24, % 0.08% N NEO HCG 2000 IU INJECTION 1 ML NEO HCG NEON LABORATORIES LTD 2000 IU 1 Each Vial , % 0.02% N EUTRIG HP 2000 IU INJECTION 1 EUTRIG HP SAMARTH LIFE SCIENCES PVT LTD 2000 IU 1 Each Vial ,89, % 3.66% Y LUTIGEN GOLD 2000 IU INJECTION 1 ML LUTIGEN GOLD SANZYME LTD 2000 IU 1 Each Vial , % 11.44% Y ORIGEN 2000 IU INJECTION 1 ORIGEN SANZYME LTD 2000 IU 1 Each Vial ,20, % 11.44% Y PUBERGEN 2000 IU INJECTION 1 ML PUBERGEN SANZYME LTD 2000 IU 1 Each Vial ,41,28, % 11.44% Y PUBERGEN HP 2000 IU INJECTION 1 PUBERGEN HP SANZYME LTD 2000 IU 1 Each Vial ,15, % 11.44% Y SIFASI HP 2000 IU INJECTION 1 ML SIFASI HP SERUM INSTITUTE OF INDIA LTD 2000 IU 1 Each Vial ,52,89, % 10.01% Y FERTIGYN 2000 IU INJECTION 1 FERTIGYN SUN PHARMA LABORATORIES LTD IU 1 Each Vial ,12, % 12.50% Y FERTIGYN HP IU INJECTION 1 FERTIGYN HP-2000 SUN PHARMA LABORATORIES LTD IU 1 Each Vial ,40,73, % 12.50% Y OVUTRIG HP 2000 IU INJECTION 1 ML OVUTRIG HP VHB LIFE SCIENCES INC 2000 IU 1 Each Vial ,32,55, % 8.68% Y CORION 2000 IU INJECTION 1 ML CORION WIN-MEDICARE PVT. LTD IU 1 Each Vial ,79, % 0.44% N HCG 2000 IU INJECTION 1 HCG ZYDUS CADILA 2000 IU 1 Each Vial , % 6.73% Y OVIDAC 2000 IU INJECTION 2 ML OVIDAC ZYDUS CADILA 2000 IU 1 Each Vial ,19, % 6.73% Y ZYHCG 2000 IU INJECTION 1 ZYHCG ZYDUS CADILA 2000 IU 1 Each Vial ,86, % 6.73% Y ZYHCG HP 2000 IU INJECTION 1 ZYHCG HP ZYDUS CADILA 2000 IU 1 Each Vial ,31, % 6.73% Y Rs. Per Vial Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price

5 S. Computataion of Retail Price based on Feb., 2016 Data under Para 6 of DPCO 2013 Nevirapine ER Tablet 400mg of M/s Emcure Pharmaceuticals Ltd Number of Companies cosisting of Market Share of 1% & Above 1 Sum of value considered for price calculation (in Lakhs) 4.99 Sum of PTR per unit considered for price calculation Number of s considered 1 Average PTR Add : 16% Retailer Margin 2.93 Retail Price (without local taxes) % Reduction with compared to Highest Price 0.00% प क व रण Description TOTAL 4,98, % Unit PTR (Rs.) (Rs.) SKU wise ) Minimumum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Retail Price (Rs.) Unit (Rs.) Considered 1 NEVIMUNE XR 400 MG TABLET 10 NEVIMUNE CIPLA LTD. 400 MG 10 TABLET % % Y Rs. Per Tablet Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price 21.22

6 Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 Paracetamol 125 mg+mefanamic Acid 50mg oral suspension of M/s Akums Drugs & Pharmaceuticals Ltd and M/s Apex Laboratories Pvt Ltd Number of Companies cosisting of Market Share of 1% & Above 9 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation 4.70 Number of s considered 11 Average PTR 0.43 Add : 16% Retailer Margin 0.07 Retail Price (without local taxes) 0.50 % Reduction with compared to Highest Price 21.82% S. प क व रण Description TOTAL 34,36,84, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) 0.17 Maximum Price (Rs.) 0.55 Average of all considered (Rs.) 0.43 Retail Price (Rs.) 0.50 ) 1 NIMUFLEX P KID 50/125 MG SUSPENSION 60 ML NIMUFLEX P ABBOTT HEALTHCARE PVT. LTD 50/125 MG 60 ML ,86, % 1.51% Y NIMCETA MF 50/125 MG SUSPENSION 60 ML NIMCETA MF ALKEM LABORATORIES LTD. 50/125 MG 60 ML ,48, % 13.65% Y SUMO L PLUS 50/125 MG SYRUP 60 ML SUMO L PLUS ALKEM LABORATORIES LTD. 50/125 MG 60 ML ,67,63, % 13.65% Y MEFTAGESIC P 50/125 MG SYRUP 60 ML MEFTAGESIC P BLUE CROSS LABORATORIES LTD 50/125 MG 60 ML ,83,33, % 19.88% Y CENTAMOL PLUS 50/125 MG SUSPENSION 60 ML CENTAMOL PLUS CENTAUR PHARMACEUTICALS PVT.LTD 50/125 MG 60 ML ,08, % 2.39% Y UNIFLEM MF 50/125 MG SUSPENSION 60 ML UNIFLEM MF CORONA 50/125 MG 60 ML ,54, % 0.07% N NUNOCK 50/125 MG SUSPENSION 60 ML NUNOCK GRANDCURE HEALTHCARE PVT. LTD. 50/125 MG 60 ML ,96, % 0.26% N TYNOL MF 50/125 MG SYRUP 60 ML TYNOL MF GUJARAT TERCE LABORATORIES LTD 50/125 MG 60 ML ,23, % 0.50% N NIMEK PARA PLUS 50/125 MG SUSPENSION 60 ML NIMEK PARA PLUS JB CHEMICALS 50/125 MG 60 ML ,36, % 0.13% N ZYDOL-P 50/125 MG SUSPENSION 60 ML ZYDOL-P JENBURKT PHARMACEUTICALS LTD 50/125 MG 60 ML ,66, % 1.21% Y DUOFLAM KID 50/125 MG SUSPENSION 60 ML DUOFLAM MANEESH PHARMACEUTICALS LTD 50/125 MG 60 ML ,07,24, % 3.12% Y MEFKIND FORTE 125/50 MG SUSPENSION 60 ML MEFKIND MANKIND PHARMACEUTICALS LTD. 125/50 MG 60 ML ,60,01, % 46.73% Y NOBEL PLUS 50/125 MG SUSPENSION 60 ML NOBEL PLUS MANKIND PHARMACEUTICALS LTD. 50/125 MG 60 ML ,46,17, % 46.73% Y DOLOMEC MF 50/125 MG SYRUP 60 ML DOLOMEC MF MCW HEALTHCARE 50/125 MG 60 ML ,65, % 0.05% N MEDOMOL-MF 50/125 MG SUSPENSION 60 ML MEDOMOL-MF MEDO PHARMA 50/125 MG 60 ML ,42, % 0.36% N DOLOPAR M 50/125 MG SUSPENSION 60 ML DOLOPAR M MICRO LABS LTD 50/125 MG 60 ML ,96,62, % 5.72% Y MEFPREX-P 50/125 MG SYRUP 60 ML MEFPREX-P SEAGULL PHARMA 50/125 MG 60 ML , % 0.01% N MEFANORM PLUS 50/125 MG SUSPENSION 60 ML MEFANORM PLUS SERUM INSTITUTE OF INDIA LTD 50/125 MG 60 ML ,71, % 0.72% N FEPANIL MEF 50/125 MG SUSPENSION 60 ML FEPANIL MEF VERITAZ HEALTHCARE LTD 50/125 MG 60 ML ,95, % 0.82% N RXMEF P 50/125 MG SUSPENSION 60 ML RXMEF P VERITAZ HEALTHCARE LTD 50/125 MG 60 ML ,97, % 0.82% N MEFAST P 50/125 MG SYRUP 60 ML MEFAST P ZUVENTUS HEALTHCARE LTD 50/125 MG 60 ML ,63, % 2.87% Y Rs. Per ML Worked out Retail Price 0.50 Claimed Retail Price 0.58 Already notified Retail Price (after 10% increase p.a. for 2 years) 0.54 Proposed Retail Price 0.50 Unit (Rs.) Considered

7 Computataion of Retail Price based on June, 2015 Data under Para 4 of DPCO 2013 Sterile water for injection/irrigation 3000ml for M/s Infutec Healthcare Ltd. Number of Companies cosisting of Market Share of 1% & Above 2 Sum of value considered for price calculation (in Lakhs) 8.96 Sum of PTR per unit considered for price calculation Number of s considered 2 Average PTR Add : 16% Retailer Margin Retail Price (without local taxes) % Reduction with compared to Highest Price 26.56% Minimumum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Retail Price (Rs.) TOTAL 8,96, % S. Description Unit PTR (Rs.) (Rs.) SKU wise (ignoring O% ) Considere d 1 Irrigation USP3000ML inj. Denis Chem Lab Limited 3000 ml 1 Each ,02, % 22.64% Y Sterile water for Irrigation 3000ml USP Ives Drug (India) Pvt Ltd ml 1 Each ,93, % 77.36% Y Rs. Per Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price

8 Computataion of Retail Price based on Jan., 2016 Data under Para 4 of DPCO 2013 Pantoprazole sodium 40mg + Domperidine 30mg capsule of M/s Windlas Biotech Ltd. Number of Companies cosisting of Market Share of 1% & Above 10 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 11 Average PTR 6.85 Add : 16% Retailer Margin 1.10 Retail Price (without local taxes) 7.95 % Reduction with compared to Highest Price 25.54% S. प क व रण Description TOTAL 4,33,30,93, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) 2.51 Maximum Price (Rs.) 9.20 Average of all considered (Rs.) 6.85 Retail Price (Rs.) 7.95 ) 1 PANDIFF 40/30 MG CAPSULE 10 PANDIFF ABBOTT HEALTHCARE PVT. LTD 40/30 MG 10 CAPSULE ,09, % 0.21% N PENTASTAR DSR 30/40 MG CAPSULE 10 PENTASTAR DSR ADCOCK INGRAM HEALTHCARE PVT LTD 30/40 MG 10 CAPSULE ,92, % 0.03% N PENTAB DSR 30/40 MG CAPSULE 10 PENTAB DSR ALEMBIC LTD 30/40 MG 10 CAPSULE ,67, % 0.05% N PAN D 30/40 MG CAPSULE SR 10 PAN D ALKEM LABORATORIES LTD. 30/40 MG 10 CAPSULE SR ,55,30,79, % 35.84% Y PANTOP D SR 30/40 MG CAPSULE SR 10 PANTOP D SR ARISTO PHARMACEUTICALS PVT.LTD 30/40 MG 10 CAPSULE SR ,14,34, % 10.19% Y PANSIO DSR 30/40 MG CAPSULE 10 PANSIO DSR AURZ PHARMACEUTICALS PVT LTD 30/40 MG 10 CAPSULE ,12, % 0.13% N REPAN DSR 30/40 MG CAPSULE 10 REPAN DSR BHARTI LIFE SCIENCES 30/40 MG 10 CAPSULE ,21, % 0.01% N PRD(BLU) 40/30 MG CAPSULE SR 10 PRD(BLU) BLUE CROSS LABORATORIES LTD 40/30 MG 10 CAPSULE SR ,77,51, % 1.56% Y PNZ D 40/30 MG CAPSULE 10 PNZ D CACHET PHARMACEUTICALS PVT LTD 40/30 MG 10 CAPSULE ,90, % 0.18% N ACIBAN DSR 30/40 MG CAPSULE SR 10 ACIBAN DSR CADILA PHARMACEUTICALS LTD 30/40 MG 10 CAPSULE SR ,64, % 0.22% N ELESEC DSR 30/40 MG CAPSULE 10 ELESEC DSR CANVARZYS PHARMACEUTICALS 30/40 MG 10 CAPSULE ,83, % 0.04% N PANTOSEC DSR 30/40 MG CAPSULE 10 PANTOSEC DSR CIPLA LTD. 30/40 MG 10 CAPSULE ,82,73, % 0.42% N PROLOC DSR 30/40 MG CAPSULE 10 PROLOC DSR COMED CHEMICALS PVT LTD 30/40 MG 10 CAPSULE ,78, % 0.06% N ULPAN DSR 30/40 MG CAPSULE 10 ULPAN DSR CORONA 30/40 MG 10 CAPSULE ,57,76, % 1.06% Y PANTIP-DSR 30/40 MG CAPSULE 10 PANTIP-DSR DAWSON HEALTHCARE PVT.LTD 30/40 MG 10 CAPSULE ,17, % 0.01% N MBCID D 40/30 MG CAPSULE SR 10 MBCID D DELCURE LIFE SCIENCES 40/30 MG 10 CAPSULE SR ,03, % 0.02% N PADUP 30/40 MG CAPSULE 10 PADUP DEYS MEDICAL 30/40 MG 10 CAPSULE ,65,49, % 0.38% N ZOVANTA D 30/40 MG CAPSULE 10 ZOVANTA D DR. REDDYS LABORATORIES LTD 30/40 MG 10 CAPSULE ,91,70, % 0.67% N PALIO D 30/40 MG CAPSULE SR 10 PALIO D DWD PHARMACEUTICALS LTD 30/40 MG 10 CAPSULE SR ,75, % 0.14% N PANTOCARD DSR 30/40 MG CAPSULE 10 PANTOCARD DSR ENDOCARD 30/40 MG 10 CAPSULE ,83, % 0.01% N ZIPANT D 30/40 MG CAPSULE SR 10 ZIPANT D FDC LTD. 30/40 MG 10 CAPSULE SR ,02,42, % 0.70% N PFANTO D 30/40 MG CAPSULE 10 PFANTO D FIDELITY LIFESCIENCE 30/40 MG 10 CAPSULE ,46, % 0.05% N PANDOSTAL 30/40 MG CAPSULE 10 PANDOSTAL GALPHA LABORATORIES LTD 30/40 MG 10 CAPSULE ,70, % 0.35% N PANDOSTAL OD 30/40 MG CAPSULE 10 PANDOSTAL OD GALPHA LABORATORIES LTD 30/40 MG 10 CAPSULE ,41,43, % 0.35% N GLANPAN DSR 30/40 MG CAPSULE 10 GLANPAN DSR GLAND PHARMA LIMITED 30/40 MG 10 CAPSULE ,22,22, % 0.28% N PPZ D 30/40 MG CAPSULE 10 PPZ D GNEXT LAB PVT LTD 30/40 MG 10 CAPSULE ,80, % 0.01% N GOPAN DSR 30/40 MG CAPSULE SR 10 GOPAN DSR GOLD LINE 30/40 MG 10 CAPSULE SR ,19, % 0.05% N PANTIN D 30/40 MG CAPSULE SR 10 PANTIN D HETERO HEALTHCARE LTD 30/40 MG 10 CAPSULE SR ,28, % 0.21% N EC PAN DSR (ICON) 30/40 MG CAPSULE 10 EC PAN DSR (ICON) ICON LIFESCIENCES 30/40 MG 10 CAPSULE ,38,58, % 0.32% N PANTIUM-DSR 30/40 MG CAPSULE SR 10 PANTIUM-DSR INTAS PHARMACEUTICALS LTD 30/40 MG 10 CAPSULE SR ,26,06, % 1.44% Y PANUM-D 30/40 MG CAPSULE SR 10 PANUM-D JB CHEMICALS 30/40 MG 10 CAPSULE SR ,85, % 0.06% N PANTAKAN DSR 30/40 MG CAPSULE 10 PANTAKAN DSR KANAD LABS 30/40 MG 10 CAPSULE ,57, % 0.04% N TOPRAZOL D 30/40 MG CAPSULE 10 TOPRAZOL D KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD(KAPL) 30/40 MG 10 CAPSULE ,20, % 0.07% N PANTOPRAZ DSR 30/40 MG CAPSULE 15 PANTOPRAZ DSR KHANDELWAL LABORATORIES LTD 30/40 MG 15 CAPSULE ,25, % 0.01% N PANTOVEL DSR 30/40 MG CAPSULE 10 PANTOVEL DSR KINEDEX HEALTH CARE PVT LTD 30/40 MG 10 CAPSULE ,80, % 0.08% N GASTROPAN DSR 30/40 MG CAPSULE 10 GASTROPAN KIVI LABS LTD 30/40 MG 10 CAPSULE ,54, % 0.01% N PENTALINK D 30/40 MG CAPSULE SR 10 PENTALINK D LINCOLN PHARMACEUTICALS LTD 30/40 MG 10 CAPSULE SR ,64, % 0.11% N P2I-D 30/40 MG CAPSULE 10 P2I-D LUPIN LTD 30/40 MG 10 CAPSULE ,93,96, % 1.14% Y Unit (Rs.) Considered

9 S. प क व रण Description Unit PTR (Rs.) (Rs.) SKU wise ) 39 NUPENTA DSR 30/40 MG CAPSULE SR 10 NUPENTA DSR MACLEODS PHARMACEUTICALS PVT.LTD 30/40 MG 10 CAPSULE SR ,13,51, % 2.57% Y ERACID D 30/40 MG CAPSULE SR 10 ERACID D MANEESH PHARMACEUTICALS LTD 30/40 MG 10 CAPSULE SR ,00,88, % 0.23% N PANTADOM 30/40 MG CAPSULE 10 PANTADOM MANKIND PHARMACEUTICALS LTD. 30/40 MG 10 CAPSULE ,34, % 3.94% Y PANTAKIND DSR 30/40 MG CAPSULE SR 6 PANTAKIND DSR MANKIND PHARMACEUTICALS LTD. 30/40 MG 6 CAPSULE SR ,03,38, % 3.94% Y MEDOCID DSR 30/40 MG CAPSULE 10 MEDOCID DSR MEDO PHARMA 30/40 MG 10 CAPSULE ,29, % 0.02% N PANTOTAB DSR 30/40 MG CAPSULE 10 PANTOTAB DSR MICRO LABS LTD 30/40 MG 10 CAPSULE ,42,00, % 0.56% N PZ 4DSR 30/40 MG CAPSULE SR 10 PZ 4DSR NATIONAL C & PHARMA 30/40 MG 10 CAPSULE SR ,18, % 0.06% N PERIZOLE DP 30/40 MG CAPSULE 10 PERIZOLE DP OBSURGE BIOTECH LTD 30/40 MG 10 CAPSULE ,37, % 0.06% N PANTOSEAL DSR 30/40 MG CAPSULE 10 PANTOSEAL DSR ORGANIC LABORATORIES 30/40 MG 10 CAPSULE ,95, % 0.02% N GELUPAN D 40/30 MG CAPSULE 10 GELUPAN D PFIZER LTD 40/30 MG 10 CAPSULE ,07, % 0.06% N MEGAZOLE DR 30/40 MG CAPSULE DR 10 MEGAZOLE DR SAF FERMION LTD 30/40 MG 10 CAPSULE DR ,25, % 0.01% N SAFEPRAZ DSR 30/40 MG CAPSULE 10 SAFEPRAZ DSR SAFFRON THERAPEUTICS PVT LTD 30/40 MG 10 CAPSULE ,46,83, % 0.34% N PANFAST DSR 30/40 MG CAPSULE 10 PANFAST DSR SANAT PRODUCTS LTD 30/40 MG 10 CAPSULE ,82, % 0.02% N PONY DSR 30/40 MG CAPSULE 10 PONY DSR SANJIVINI BIOTECH PRIVATE LIMITED 30/40 MG 10 CAPSULE ,98, % 0.09% N PANIDO DSR 30/40 MG CAPSULE 10 PANIDO DSR SHINE PHARMACEUTICALS LTD 30/40 MG 10 CAPSULE ,11,59, % 0.26% N PERD SR 30/40 MG CAPSULE 10 PERD SKYMAX LABORATORIES LTD. 30/40 MG 10 CAPSULE ,24, % 0.03% N PANTOCID DSR 30/40 MG CAPSULE SR 10 PANTOCID DSR SUN PHARMA LABORATORIES LTD. 30/40 MG 10 CAPSULE SR ,17,48,91, % 27.11% Y PANTIME DSR 30/40 MG CAPSULE 10 PANTIME DSR VOTARY LABORATORIES (I) LTD. 30/40 MG 10 CAPSULE ,09, % 0.02% N PANTASTIC D 30/40 MG CAPSULE 10 PANTASTIC D WANBURY LTD 30/40 MG 10 CAPSULE ,06,90, % 0.25% N BELYCOOL DSR 30/40 MG CAPSULE 15 BELYCOOL DSR WINDLAS BIOTECH LTD 30/40 MG 15 CAPSULE ,59, % 0.02% N PANSA DSR 30/40 MG CAPSULE 10 PANSA DSR ZUVENTUS HEALTHCARE LTD 30/40 MG 10 CAPSULE ,18,10, % 0.27% N PANTODAC DSR 30/40 MG CAPSULE SR 10 PANTODAC DSR ZYDUS CADILA 30/40 MG 10 CAPSULE SR ,36,15, % 7.93% Y Rs. Per Capsule Worked out Retail Price 7.95 Claimed Retail Price Already notified Retail Price (with 10% 8.39 increase p.a.) Proposed Retail Price 7.95 Unit (Rs.) Considered

10 Computataion of Retail Price based on Jan 2016 Data under Para 4 of DPCO 2013 Rabeprazole sodium 20mg + Domperidine 30mg capsule of M/s Windlas Biotech Ltd. Number of Companies cosisting of Market Share of 1% & Above 24 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 38 Average PTR 5.92 Add : 16% Retailer Margin 0.95 Retail Price (without local taxes) 6.87 % Reduction with compared to Highest Price 37.82% S. प क व रण Description TOTAL 3,07,66,82, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) 1.40 Maximum Price (Rs.) 9.52 Average of all considered (Rs.) 5.92 Retail Price (Rs.) 6.87 ) 1 VULPRAZ DSR 30/20 MG CAPSULE 10 VULPRAZ AAGAM LIFE SCIENCES PVT.LTD 30/20 MG 10 CAPSULE ,28, % 0.01% N R CID PLUS 30/20 MG CAPSULE SR 10 R CID PLUS ABBOTT HEALTHCARE PVT. LTD 30/20 MG 10 CAPSULE SR ,74, % 7.77% Y ESOGARD 30/20 MG CAPSULE SR 10 ESOGARD ABBOTT HEALTHCARE PVT. LTD 30/20 MG 10 CAPSULE SR ,26,74, % 7.77% Y SET GI 30/20 MG CAPSULE 10 SET GI ABBOTT HEALTHCARE PVT. LTD 30/20 MG 10 CAPSULE ,70,41, % 7.77% Y ALGIBRA D 30/20 MG CAPSULE 10 ALGIBRA D ADCOCK INGRAM HEALTHCARE PVT LTD 30/20 MG 10 CAPSULE ,47, % 0.13% N RABAZIO DSR 30/20 MG CAPSULE 10 RABAZIO DSR AGIO PHARMACEUTICALS 30/20 MG 10 CAPSULE ,51, % 0.01% N REBOK DSR 30/20 MG CAPSULE 10 REBOK DSR AGM BIOTEC 30/20 MG 10 CAPSULE ,79, % 0.03% N RABECAR D 30/20 MG CAPSULE 10 RABECAR D ALBATROSS HEALTH CARE PVT LTD 30/20 MG 10 CAPSULE ,95, % 0.02% N DEREK D 30/20 MG CAPSULE 10 DEREK D ALBERT DAVID 30/20 MG 10 CAPSULE ,03,10, % 0.66% N RAPEED D 30/20 MG CAPSULE 10 RAPEED D ALKEM LABORATORIES LTD. 30/20 MG 10 CAPSULE ,16,45, % 1.03% Y RABANGG DSR 30/20 MG CAPSULE 10 RABANGG DSR ANGLO-FRENCH DRUGS & INDUSTRIES LTD. 30/20 MG 10 CAPSULE ,26, % 0.02% N FAST DSR 30/20 MG CAPSULE 10 FAST DSR APPLE LIFESCIENCE 30/20 MG 10 CAPSULE ,51, % 0.05% N CHILKUL DSR 30/20 MG CAPSULE 10 CHILKUL DSR APTUS PHARMA PVT.LTD 30/20 MG 10 CAPSULE ,01, % 0.03% N RABEZOL DSR 30/20 MG CAPSULE SR 10 RABEZOL DSR ARISTO PHARMACEUTICALS PVT.LTD 30/20 MG 10 CAPSULE SR ,32,97, % 2.12% Y RABITOP DSR 30/20 MG CAPSULE 10 RABITOP DSR ARISTO PHARMACEUTICALS PVT.LTD 30/20 MG 10 CAPSULE ,08, % 2.12% Y RABITOP D 30/20 MG CAPSULE SR 10 RABITOP D ARISTO PHARMACEUTICALS PVT.LTD 30/20 MG 10 CAPSULE SR ,98,31, % 2.12% Y RZ D 30/20 MG CAPSULE SR 10 RZ D AURZ PHARMACEUTICALS PVT LTD 30/20 MG 10 CAPSULE SR ,75, % 0.02% N AXIRAB DSR 30/20 MG CAPSULE 10 AXIRAB DSR AVIS LIFE CARE PVT LTD 30/20 MG 10 CAPSULE ,69, % 0.01% N RABIO 30/20 MG CAPSULE 10 RABIO BENNET PHARMACEUTICALS LIMITED 30/20 MG 10 CAPSULE ,01, % 0.01% N ODIRAB D 30/20 MG CAPSULE 10 ODIRAB D BIOCHEM PHARMACEUTICAL INDS 30/20 MG 10 CAPSULE ,82, % 0.13% N STOMECK DSR 30/20 MG CAPSULE 10 STOMECK DSR BIOMIICRON PHARMACEUTICALS 30/20 MG 10 CAPSULE ,20, % 0.04% N RRD 30/20 MG CAPSULE SR 10 RRD BLUE CROSS LABORATORIES LTD 30/20 MG 10 CAPSULE SR ,78,23, % 2.20% Y PYLOREX DSR (BSP PHARMACEUTICALS) 30/20 MG CAPSULE 10 PYLOREX DSR (BSP PHARMACEUTICALS) BSP PHARMACEUTICALS 30/20 MG 10 CAPSULE ,61, % 0.02% N RABELOC RD 30/20 MG CAPSULE SR 10 RABELOC RD CADILA PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE SR ,42,54, % 1.76% Y RABECER D SR 30/20 MG CAPSULE SR 10 RABECER D SR CIPLA LTD. 30/20 MG 10 CAPSULE SR ,65, % 4.17% Y RABICIP D 30/20 MG CAPSULE SR 10 RABICIP D CIPLA LTD. 30/20 MG 10 CAPSULE SR ,34,99, % 4.17% Y RABICIP D 30/20 MG CAPSULE SR 15 RABICIP D CIPLA LTD. 30/20 MG 15 CAPSULE SR ,22, % 4.17% Y MAC RD 30/20 MG CAPSULE 10 MAC RD CORONA 30/20 MG 10 CAPSULE ,55,91, % 2.46% Y HIKE 30/20 MG CAPSULE 10 HIKE DALES PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE ,75, % 0.01% N RABAN DSR 30/20 MG CAPSULE 10 RABAN DSR DOWELL PHARMACEUTICAL 30/20 MG 10 CAPSULE ,64, % 0.10% N HULEZ DSR 30/20 MG CAPSULE 10 HULEZ DSR DR. JOHNS LABORATORIES PVT LTD 30/20 MG 10 CAPSULE ,93, % 0.18% N OLEZ DSR 30/20 MG CAPSULE 10 OLEZ DSR DR. JOHNS LABORATORIES PVT LTD 30/20 MG 10 CAPSULE ,61, % 0.18% N RAZO D 30/20 MG CAPSULE SR 10 RAZO D DR. REDDYS LABORATORIES LTD 30/20 MG 10 CAPSULE SR ,85,43, % 4.50% Y RAVIER D 30/20 MG CAPSULE 10 RAVIER D EMENOX HEALTHCARE PVT LTD 30/20 MG 10 CAPSULE ,28, % 0.15% N RABEMON DSR 30/20 MG CAPSULE 10 RABEMON DSR ERIS LIFE SCIENCES PVT LTD 30/20 MG 10 CAPSULE ,08, % 2.70% Y RABONIK D 30/20 MG CAPSULE SR 15 RABONIK D ERIS LIFE SCIENCES PVT LTD 30/20 MG 15 CAPSULE SR ,03,22, % 2.70% Y PEPCIA D 30/20 MG CAPSULE SR 10 PEPCIA D FDC LTD. 30/20 MG 10 CAPSULE SR ,23,25, % 1.70% Y GERDRID 30/20 MG CAPSULE 10 GERDRID FOURRTS INDIA LABORATORIES PVT. LTD 30/20 MG 10 CAPSULE ,02,42, % 0.33% N RABINY DSR 30/20 MG CAPSULE 10 RABINY DSR GALENIC PHARMACEUTICALS PVT.LTD 30/20 MG 10 CAPSULE ,16, % 0.01% N PARIT D 30/20 MG CAPSULE 10 PARIT D GLAXOSMITHKLINE PHARMACEUTICALS LTD. 30/20 MG 10 CAPSULE ,29,86, % 1.72% Y RABEFINE DSR 30/20 MG CAPSULE SR 10 RABEFINE DSR GLENMARK PHARMACEUTICALS LTD. 30/20 MG 10 CAPSULE SR ,56, % 0.13% N ROZ D 30/20 MG CAPSULE 10 ROZ D GRAF LABORATORIES PVT LTD 30/20 MG 10 CAPSULE ,85, % 0.02% N RABTER 30/20 MG CAPSULE SR 10 RABTER GUJARAT TERCE LABORATORIES LTD 30/20 MG 10 CAPSULE SR ,33, % 0.01% N RAPER D 30/20 MG CAPSULE 10 RAPER D HELIOS PHARMACEUTICALS 30/20 MG 10 CAPSULE ,20, % 0.09% N RABEZ D 30/20 MG CAPSULE SR 10 RABEZ D HETERO HEALTHCARE LTD 30/20 MG 10 CAPSULE SR ,66,20, % 1.19% Y REBAZ D 30/20 MG CAPSULE 10 REBAZ D INDCHEMIE HEALTH SPECIALITIES PVT. LTD. 30/20 MG 10 CAPSULE ,49, % 0.05% N REPSIA-D 30/20 MG CAPSULE 10 REPSIA-D INDI PHARMA 30/20 MG 10 CAPSULE ,54, % 0.12% N 3.89 Unit (Rs.) Considered

11 S. प क व रण Description Unit PTR (Rs.) (Rs.) SKU wise ) 48 PEPCHEK 30/20 MG CAPSULE SR 10 PEPCHEK INDOCO REMEDIES LTD 30/20 MG 10 CAPSULE SR ,21,63, % 1.14% Y CYCLOCHEK 30/20 MG CAPSULE SR 10 CYCLOCHEK INDOCO REMEDIES LTD 30/20 MG 10 CAPSULE SR ,28,17, % 1.14% Y RABIUM-DSR 30/20 MG CAPSULE 10 RABIUM-DSR INTAS PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE ,31,98, % 6.28% Y ACERA 30/20 MG CAPSULE SR 30 ACERA IPCA LABORATORIES PVT LTD. 30/20 MG 30 CAPSULE SR ,81, % 3.10% Y ACERA D 30/20 MG CAPSULE SR 10 ACERA D IPCA LABORATORIES PVT LTD. 30/20 MG 10 CAPSULE SR ,48,45, % 3.10% Y REBEN DSR 30/20 MG CAPSULE 10 REBEN DSR JARUN PHARMACEUTICALS 30/20 MG 10 CAPSULE ,88, % 0.03% N RABERA DSR 30/20 MG CAPSULE SR 10 RABERA DSR JENBURKT PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE SR ,47, % 0.27% N ENTORAB DSR 30/20 MG CAPSULE 10 ENTORAB DSR JUPITER PHARMACEUTICALS 30/20 MG 10 CAPSULE ,37, % 0.08% N KEPREB D 30/20 MG CAPSULE SR 10 KEPREB D KEPLER HEALTH CARE 30/20 MG 10 CAPSULE SR ,67, % 0.06% N RAB D 30/20 MG CAPSULE 10 RAB D KHANDELWAL LABORATORIES LTD 30/20 MG 10 CAPSULE ,44,96, % 0.80% N ZOOL DSR 30/20 MG CAPSULE 10 ZOOL DSR KIVI LABS LTD 30/20 MG 10 CAPSULE ,36, % 0.03% N REBOZEN DSR 30/20 MG CAPSULE 10 REBOZEN DSR LEEFORD HEALTHCARE 30/20 MG 10 CAPSULE ,36, % 0.01% N ROBILINK D SR 30/20 MG CAPSULE SR 10 ROBILINK D SR LINCOLN PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE SR ,19,74, % 0.71% N RABLET-D 30/20 MG CAPSULE 10 RABLET-D LUPIN LTD 30/20 MG 10 CAPSULE ,64,65, % 16.79% Y ERB DSR 30/20 MG CAPSULE 10 ERB DSR LYPHOMED REMEDIES P LTD 30/20 MG 10 CAPSULE ,10, % 0.02% N GENPRAZ DSR 30/20 MG CAPSULE SR 10 GENPRAZ DSR MACLEODS PHARMACEUTICALS PVT.LTD 30/20 MG 10 CAPSULE SR ,88,85, % 0.61% N RABEKIND DSR 30/20 MG CAPSULE SR 10 RABEKIND DSR MANKIND PHARMACEUTICALS LTD. 30/20 MG 10 CAPSULE SR ,84,89, % 6.45% Y RABETAC D 30/20 MG CAPSULE 10 RABETAC D MAPRA LABORATORIES PVT. LTD 30/20 MG 10 CAPSULE ,11, % 0.08% N RABEFIT DSR 30/20 MG CAPSULE 10 RABEFIT DSR MARC PHARMA 30/20 MG 10 CAPSULE ,87, % 0.04% N RABEVERA DSR 30/20 MG CAPSULE 10 RABEVERA DSR MCASTRO PHARMA 30/20 MG 10 CAPSULE ,33, % 0.01% N REPRAZ D 30/20 MG CAPSULE 10 REPRAZ D MEDLEY PHARMACEUTICALS 30/20 MG 10 CAPSULE ,95, % 0.99% N DOMRAB 30/20 MG CAPSULE SR 10 DOMRAB MEDLEY PHARMACEUTICALS 30/20 MG 10 CAPSULE SR ,91,62, % 0.99% N ROO RD 30/20 MG CAPSULE 10 ROO RD MEDOZ PHARMA 30/20 MG 10 CAPSULE ,84, % 0.03% N GASTRAZOLE D 30/20 MG CAPSULE 10 GASTRAZOLE D MEYER ORGANICS PVT. LTD 30/20 MG 10 CAPSULE ,73, % 0.19% N RABIROS D SR 30/20 MG CAPSULE SR 10 RABIROS D SR MICRO LABS LTD 30/20 MG 10 CAPSULE SR ,12, % 2.86% Y RABIROS D 30/20 MG CAPSULE SR 10 RABIROS D MICRO LABS LTD 30/20 MG 10 CAPSULE SR ,99,34, % 2.86% Y HELIRAB D 30/20 MG CAPSULE 10 HELIRAB D MICRO LABS LTD 30/20 MG 10 CAPSULE ,65,75, % 2.86% Y DOMZ RB 30/20 MG CAPSULE 10 DOMZ RB MMC HEALTHCARE LTD. 30/20 MG 10 CAPSULE ,87, % 0.10% N ROBEZOLE D 30/20 MG CAPSULE 15 ROBEZOLE D MORACEAE PHARMACEUTICALS PVT LTD 30/20 MG 15 CAPSULE ,39, % 0.16% N RABIPEN DSR 30/20 MG CAPSULE 10 RABIPEN DSR MOREPEN LABORATORIES LIMITED 30/20 MG 10 CAPSULE ,03, % 0.16% N RABSULES D 30/20 MG CAPSULE 10 RABSULES D NULIFE PHARMACEUTICALS 30/20 MG 10 CAPSULE ,50, % 0.02% N PERIDUCERD 30/20 MG CAPSULE 10 PERIDUCERD OBSURGE BIOTECH LTD 30/20 MG 10 CAPSULE ,46, % 0.04% N ORPRO DM 30/20 MG CAPSULE SR 10 ORPRO DM ORDAIN HEALTHCARE PVT. LTD 30/20 MG 10 CAPSULE SR ,50, % 0.05% N ENBA 30/20 MG CAPSULE 10 ENBA PANACEA BIOTEC LTD 30/20 MG 10 CAPSULE ,32, % 0.23% N RABEDAL D 30/20 MG CAPSULE 10 RABEDAL D PHARMED LTD 30/20 MG 10 CAPSULE ,19, % 0.14% N RBP DSR 30/20 MG CAPSULE 10 RBP DSR PSYCHOTROPICS INDIA LTD 30/20 MG 10 CAPSULE ,53, % 0.03% N RABIQ D 30/20 MG CAPSULE 10 RABIQ D QUE PHARMA PVT. LTD. 30/20 MG 10 CAPSULE ,70, % 0.06% N ROPRAZ D SR 30/20 MG CAPSULE SR 10 ROPRAZ D SR RANBAXY LABORATORIES LTD 30/20 MG 10 CAPSULE SR ,31, % 2.37% Y ROLES D 30/20 MG CAPSULE 10 ROLES D RANBAXY LABORATORIES LTD 30/20 MG 10 CAPSULE ,19,48, % 2.37% Y RAPTAC DSR 30/20 MG CAPSULE 10 RAPTAC DSR RAPROSS PHARMACEUTICALS PVT LTD 30/20 MG 10 CAPSULE ,12, % 0.04% N ZOPRA DSR 30/20 MG CAPSULE 10 ZOPRA DSR RAVENBHEL PHARMACEUTICALS PVT LTD. 30/20 MG 10 CAPSULE ,60, % 0.01% N RD OD 30/20 MG CAPSULE 10 RD OD RESILIENT COSMECEUTICALS PRIVATE LIMITED 30/20 MG 10 CAPSULE ,05, % 0.11% N RABOPEP DSR 30/20 MG CAPSULE 10 RABOPEP DSR SEAGULL PHARMA 30/20 MG 10 CAPSULE ,31, % 0.10% N ZRD 30/20 MG CAPSULE 10 ZRD SERUM INSTITUTE OF INDIA LTD 30/20 MG 10 CAPSULE ,57, % 0.08% N SHINORAB D 30/20 MG CAPSULE 10 SHINORAB D SHINE PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE ,97, % 0.02% N RABSIG DSR 30/20 MG CAPSULE 10 RABSIG DSR SIGNOVA PHARMA (P) LTD 30/20 MG 10 CAPSULE ,35,41, % 0.77% N NAYCID D 30/20 MG CAPSULE 10 NAYCID D SOICO PHARMACEUTICALS LTD 30/20 MG 10 CAPSULE ,70, % 0.01% N ZEBRA DSR 30/20 MG CAPSULE 10 ZEBRA DSR STRIDES SHASUN LIMITED 30/20 MG 10 CAPSULE ,97, % 0.23% N R-DSR 30/20 MG CAPSULE 10 R-DSR STRIDES SHASUN LIMITED 30/20 MG 10 CAPSULE ,45, % 0.23% N NOFLUX 30/20 MG CAPSULE 10 NOFLUX SYNCOM FORMULATIONS (I) LIMITED 30/20 MG 10 CAPSULE ,35,59, % 0.44% N ULCIRAB D 30/20 MG CAPSULE 10 ULCIRAB D TALENT HEALTHCARE 30/20 MG 10 CAPSULE ,87, % 0.05% N RABEMAX DSR 30/20 MG CAPSULE 10 RABEMAX DSR TIDAL LABORATORIES PVT LTD 30/20 MG 10 CAPSULE ,23, % 0.03% N REPRAL D 30/20 MG CAPSULE 10 REPRAL D TORRENT PHARMACEUTICALS LTD. 30/20 MG 10 CAPSULE ,39, % 0.06% N RBSON D 30/20 MG CAPSULE 10 RBSON D UNISON PHARMACEUTICALS 30/20 MG 10 CAPSULE ,49,85, % 1.14% Y DREGO D 30/20 MG CAPSULE 10 DREGO D USV LTD 30/20 MG 10 CAPSULE ,22,32, % 3.97% Y RABZER D 30/20 MG CAPSULE SR 10 RABZER D WALLACE PHARMACEUTICALS LTD. 30/20 MG 10 CAPSULE SR ,19,95, % 0.39% N OSTEOCID D 30/20 MG CAPSULE 10 OSTEOCID D WANBURY LTD 30/20 MG 10 CAPSULE ,89,42, % 3.35% Y RABIPLUS D 30/20 MG CAPSULE SR 10 RABIPLUS D WANBURY LTD 30/20 MG 10 CAPSULE SR ,40,82, % 3.35% Y PRORAB D 30/20 MG CAPSULE SR 10 PRORAB D WOCKHARDT LTD 30/20 MG 10 CAPSULE SR ,72, % 0.28% N ZORAB DSR 30/20 MG CAPSULE 10 ZORAB DSR ZOTA PHARMACEUTICALS 30/20 MG 10 CAPSULE ,19, % 0.05% N RABET DSR 30/20 MG CAPSULE 10 RABET DSR ZOTA PHARMACEUTICALS 30/20 MG 10 CAPSULE ,94, % 0.05% N RABIFAST-DSR 30/20 MG CAPSULE 10 RABIFAST-DSR ZUVENTUS HEALTHCARE LTD 30/20 MG 10 CAPSULE ,00,99, % 2.54% Y RABIFAST-DSR 30/20 MG CAPSULE 15 RABIFAST-DSR ZUVENTUS HEALTHCARE LTD 30/20 MG 15 CAPSULE ,79,14, % 2.54% Y HAPPI D 30/20 MG CAPSULE SR 10 HAPPI D ZYDUS CADILA 30/20 MG 10 CAPSULE SR ,34,01, % 6.61% Y Unit (Rs.) Considered

12 S. प क व रण Description Unit PTR (Rs.) (Rs.) SKU wise ) 112 BIPRA D 30/20 MG CAPSULE 10 BIPRA D ZYPHARS PHARMACEUTICS PVT. LTD 30/20 MG 10 CAPSULE ,36, % 0.07% N 7.24 Unit (Rs.) Considered Rs. Per Capsule Worked out Retail Price 6.87 Claimed Retail Price 9.95 Already notified Retail Price - Proposed Retail Price 6.87

13 Computataion of Retail Price based on January 2016 Data under Para 4 of DPCO 2013 Acelofenac 100mg+ Paracetamol 325 mg tablet of M/s Windlas Biotech Ltd Number of Companies cosisting of Market Share of 1% & Above 17 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 20 Average PTR 2.50 Add : 16% Retailer Margin 0.40 Retail Price (without local taxes) 2.90 % Reduction with compared to Highest Price 58.47% S. प क व रण Description TOTAL 28,41,08, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) 0.73 Maximum Price (Rs.) 6.02 Average of all considered (Rs.) 2.50 Retail Price (Rs.) 2.90 ) 1 ACEVAH P 100/325 MG TABLET 10 ACEVAH P ABBOTT HEALTHCARE PVT. LTD 100/325 MG 10 TABLET ,32, % 0.12% N ZYCLONAC P 100/325 MG TABLET 10 ZYCLONAC P AKESISS PHARMA (P) LTD 100/325 MG 10 TABLET ,35, % 1.31% Y EQUIDOL P 100/325 MG TABLET 10 EQUIDOL P AKUMENTIS HEALTHCARE LTD 100/325 MG 10 TABLET ,74,10, % 9.65% Y ANAFLAM XP 100/325 MG TABLET 10 ANAFLAM XP ALBERT DAVID 100/325 MG 10 TABLET ,80,42, % 9.87% Y ACELOFLAM XP 100/325 MG TABLET 15 ACELOFLAM XP ALKEM LABORATORIES LTD. 100/325 MG 15 TABLET ,73, % 2.10% Y FENCETA NOVO 100/325 MG TABLET 10 FENCETA NOVO ALKEM LABORATORIES LTD. 100/325 MG 10 TABLET ,71, % 2.10% Y ACIWAR-P 100/325 MG TABLET 10 ACIWAR-P BIO WARRIORS PHARMACEUTICALS PVT LTD 100/325 MG 10 TABLET ,77, % 0.17% N DOLOSTAT PC 100/325 MG TABLET 10 DOLOSTAT PC BLUE CROSS LABORATORIES LTD 100/325 MG 10 TABLET ,60, % 3.05% Y ZACY P 100/325 MG TABLET 10 ZACY P COMED CHEMICALS PVT LTD 100/325 MG 10 TABLET ,44, % 1.71% Y COMBIPARA 100/325 MG TABLET 10 COMBIPARA DELCURE LIFE SCIENCES 100/325 MG 10 TABLET ,06, % 1.62% Y XREL 100/325 MG TABLET 10 XREL DEYS MEDICAL 100/325 MG 10 TABLET ,87, % 2.00% Y ACENIP 100/325 MG TABLET 10 ACENIP DIVINE LIFECARE PVT LTD 100/325 MG 10 TABLET , % 0.02% N PYRIGESIC A 100/325 MG TABLET 10 PYRIGESIC A EAST INDIA PHARMACEUTICAL WORKS LTD. 100/325 MG 10 TABLET ,84, % 1.54% Y NEXONAC P 100/325 MG TABLET 10 NEXONAC P EMENOX HEALTHCARE PVT LTD 100/325 MG 10 TABLET ,94, % 0.31% N ENDONAC P 100/325 MG TABLET 10 ENDONAC P ENDOCARD 100/325 MG 10 TABLET ,86, % 0.07% N ENTOGESIC 100/325 MG TABLET 10 ENTOGESIC ENTOD PHARMACEUTICALS LTD 100/325 MG 10 TABLET ,02, % 0.04% N FLANC P 100/325 MG TABLET 10 FLANC P GENNEXT LIFE SCIENCES 100/325 MG 10 TABLET ,91, % 0.07% N NUFLEXILOR 100/325 MG TABLET 10 NUFLEXILOR GLENMARK PHARMACEUTICALS LTD. 100/325 MG 10 TABLET ,34, % 2.19% Y ALOCK P 100/325 MG TABLET 10 ALOCK P GODDRES PHARMACEUTICALS LTD 100/325 MG 10 TABLET ,31, % 0.93% N TREMENDUS PLUS 100/325 MG TABLET 10 TREMENDUS PLUS GRANDCURE HEALTHCARE PVT. LTD. 100/325 MG 10 TABLET ,98, % 0.11% N NUMOL A 100/325 MG TABLET 10 NUMOL A KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD(KAPL) 100/325 MG 10 TABLET ,30, % 0.79% N TWAGIC 100/325 MG TABLET 10 TWAGIC KEPLER HEALTH CARE 100/325 MG 10 TABLET ,14, % 0.74% N RELANAC PLUS 100/325 MG TABLET 10 RELANAC PLUS LUPIN LTD 100/325 MG 10 TABLET ,72, % 0.06% N DOLOKIND PLUS 100/325 MG TABLET 10 DOLOKIND PLUS MANKIND PHARMACEUTICALS LTD. 100/325 MG 10 TABLET ,98,93, % 47.80% Y GUDGESIC PLUS 100/325 MG TABLET 10 GUDGESIC PLUS MANKIND PHARMACEUTICALS LTD. 100/325 MG 10 TABLET ,42, % 47.80% Y MAHAGESIC PLUS RF 100/325 MG TABLET 10 MAHAGESIC PLUS RF MANKIND PHARMACEUTICALS LTD. 100/325 MG 10 TABLET ,58, % 47.80% Y DOLOMEC ACE 100/325 MG TABLET 10 DOLOMEC ACE MCW HEALTHCARE 100/325 MG 10 TABLET , % 0.02% N CANEFO PLUS 100/325 MG TABLET 10 CANEFO PLUS MEDO PHARMA 100/325 MG 10 TABLET ,69, % 0.73% N ACEPAA 100/325 MG TABLET 10 ACEPAA MEDOZ PHARMA 100/325 MG 10 TABLET , % 0.02% N AKUFLEX P 100/325 MG TABLET 10 AKUFLEX P MEGHA HEALTHCARE 100/325 MG 10 TABLET , % 0.02% N GAG PR 100/325 MG TABLET 10 GAG PR MORACEAE PHARMACEUTICALS PVT LTD 100/325 MG 10 TABLET ,15, % 1.27% Y ULTRANAC P 100/325 MG TABLET 10 ULTRANAC P OBSURGE BIOTECH LTD 100/325 MG 10 TABLET ,14, % 1.69% Y DELUPA P 100/325 MG TABLET 10 DELUPA P PANACEA BIOTEC LTD 100/325 MG 10 TABLET , % 0.03% N RUCADOL P 100/325 MG TABLET 10 RUCADOL P RAVENBHEL PHARMACEUTICALS PVT LTD. 100/325 MG 10 TABLET ,15, % 0.08% N ACPL 100/325 MG TABLET 10 ACPL REGARDIA PHARMACEUTICALS 100/325 MG 10 TABLET , % 0.02% N REXONAC-P 100/325 MG TABLET 10 REXONAC-P REXION HEALTHCARE PVT.LTD 100/325 MG 10 TABLET , % 0.02% N SAFRONAC P 100/325 MG TABLET 10 SAFRONAC P SAFFRON THERAPEUTICS PVT LTD 100/325 MG 10 TABLET ,84, % 2.35% Y SAFEACT 100/325 MG TABLET 10 SAFEACT SH PHARMACEUTICALS LTD 100/325 MG 10 TABLET ,21, % 0.82% N TOPNAC P 100/325 MG TABLET 10 TOPNAC P SYSTOPIC LABORATORIES LTD-MEM 100/325 MG 10 TABLET ,13,79, % 4.01% Y ACEGESIC 100/325 MG TABLET 10 ACEGESIC TORRENT PHARMACEUTICALS LTD. 100/325 MG 10 TABLET ,41, % 1.07% Y FEPRA P 100/325 MG TABLET 10 FEPRA P TRITON HEALTH CARE PVT LTD 100/325 MG 10 TABLET ,98, % 0.25% N ZULU P 100/325 MG TABLET 10 ZULU P UNICHEM LABORATORIES LTD 100/325 MG 10 TABLET ,58, % 1.22% Y BETAFLAM P 100/325 MG TABLET 10 BETAFLAM P VILCO LABORATORIES PVT. LTD 100/325 MG 10 TABLET , % 0.02% N TECHDOL 100/325 MG TABLET 10 TECHDOL ZOVAITALIA BIO TECH 100/325 MG 10 TABLET , % 0.02% N ACEFEX-P 100/325 MG TABLET 10 ACEFEX-P ZYDUS CADILA 100/325 MG 10 TABLET ,60, % 0.13% N 0.86 Rs. Per Tablet Worked out Retail Price 2.90 Claimed Retail Price 3.20 Already notified Retail Price (with 10% increase 3.05 p.a.) Proposed Retail Price 2.90 Unit (Rs.) Considered

14 S. Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 Trypsin 48 mg + Bromelain 90 mg+ Rutoside Trihydrate BP 100mg+ Diclofenac Sodium IP 50mg Tablet for M/s Akums Drugs & Pharma. Ltd./M/s Sun Pharma Ltd. Number of Companies cosisting of Market Share of 1% & Above 13 Sum of value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 15 Average PTR Add : 16% Retailer Margin 1.99 Retail Price (without local taxes) % Reduction with compared to Highest Price 7.98% प क व रण Description TOTAL 62,12,33, % Unit PTR (Rs.) (Rs.) SKU wise Minimumum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Retail Price (Rs.) ) 1 RUTOFLAM 100/90/50/48 MG TABLET 10 RUTOFLAM AKUMENTIS HEALTHCARE LTD 100/90/50/48 MG 10 TABLET ,66,10, % 7.50% Y ZYMOFLAM D 48/100/90/50 MG TABLET 10 ZYMOFLAM D ARISTO PHARMACEUTICALS PVT.LTD 48/100/90/50 MG 10 TABLET ,42,01, % 10.33% Y XYMOHEAL D 48/100/90/50 MG TABLET 10 XYMOHEAL D CORONA 48/100/90/50 MG 10 TABLET ,81,12, % 9.35% Y JUBIFLAM PLUS 48/100/90/50 MG TABLET 10 JUBIFLAM PLUS DR. JOHNS LABORATORIES PVT LTD 48/100/90/50 MG 10 TABLET ,27, % 0.12% N MARIHEAL D 48/100/90/50 MG TABLET 10 MARIHEAL D EMENOX HEALTHCARE PVT LTD 48/100/90/50 MG 10 TABLET ,47, % 0.51% N ENZOSAFE D 48/100/90/50 MG TABLET 10 ENZOSAFE D FORGEN HEALTHCARE LTD. 48/100/90/50 MG 10 TABLET ,04, % 0.16% N ENZO D XT 48/100/90/50 MG TABLET 10 ENZO D GODDRES PHARMACEUTICALS LTD 48/100/90/50 MG 10 TABLET ,18, % 0.13% N MUSCOFLEX FORTE 48/100/90/50 MG TABLET 10 MUSCOFLEX FORTE INDCHEMIE HEALTH SPECIALITIES PVT. LTD. 48/100/90/50 MG 10 TABLET ,28, % 0.13% N FLAMAR 3D 48/100/90/50 MG TABLET 10 FLAMAR 3D INDOCO REMEDIES LTD 48/100/90/50 MG 10 TABLET ,07, % 1.93% Y TRYBR-D 48/100/90 /50MG TABLET 10 TRYBR-D INDOCO REMEDIES LTD 48/100/90 /50MG 10 TABLET ,24, % 1.93% Y IMPROVZ DC 100/90/50/48 MG TABLET 10 IMPROVZ DC KINEDEX HEALTH CARE PVT LTD 100/90/50/48 MG 10 TABLET ,81, % 0.53% N COEVITENZ D 48/100/90/50 MG TABLET 10 COEVITENZ D KOYE PHARMACEUTICALS PVT. LTD. 48/100/90/50 MG 10 TABLET ,29, % 0.57% N ENZOHEAL D 48/100/90/50 MG TABLET 10 ENZOHEAL D MACLEODS PHARMACEUTICALS PVT.LTD 48/100/90/50 MG 10 TABLET ,24,36, % 37.93% Y ENZOMAC PLUS 48/100/90/50 MG TABLET 10 ENZOMAC PLUS MACLEODS PHARMACEUTICALS PVT.LTD 48/100/90/50 MG 10 TABLET ,32,06, % 37.93% Y RUTOHEAL D 48/90/100/50 MG TABLET 10 RUTOHEAL D MANKIND PHARMACEUTICALS LTD. 48/90/100/50 MG 10 TABLET ,73,24, % 10.84% Y TRIPCY D 48/100/90/50 MG TABLET 10 TRIPCY D MED MANOR ORGANICS PVT LTD. 48/100/90/50 MG 10 TABLET ,93, % 0.79% N ENZOIPS PLUS 48/100/90/50 MG TABLET 10 ENZOIPS PLUS MMC HEALTHCARE LTD. 48/100/90/50 MG 10 TABLET ,23, % 1.15% Y NESTDOL RT 48/100/90/50 MG TABLET 10 NESTDOL RT NEST PHARMA 48/100/90/50 MG 10 TABLET , % 0.01% N SERADIC PLUS 48/100/90/50 MG TABLET 10 SERADIC PLUS OBSURGE BIOTECH LTD 48/100/90/50 MG 10 TABLET ,87,15, % 4.62% Y BTR D 100/90/50/48 MG TABLET 10 BTR D OVERSEAS HEALTHCARE PVT LTD. 100/90/50/48 MG 10 TABLET ,02,47, % 4.87% Y ENZEM PLUS 48/100/90/50 MG TABLET 10 ENZEM PLUS SAFFRON THERAPEUTICS PVT LTD 48/100/90/50 MG 10 TABLET ,50, % 1.34% Y DEFLATE 48/100/90/50 MG TABLET 10 DEFLATE SHREYA LIFE SCIENCES PVT. LTD 48/100/90/50 MG 10 TABLET ,82, % 0.05% N BRTGESIC-D 48/100/90/50 MG TABLET 10 BRTGESIC-D SIGNITY PHARMACEUTICALS PVT LTD 48/100/90/50 MG 10 TABLET ,21, % 0.02% N MYOHEAL D 48/100/90/50 MG TABLET 10 MYOHEAL D STRIDES SHASUN LIMITED 48/100/90/50 MG 10 TABLET ,43, % 0.33% N INVILIN PLUS 48/100/90/50 MG TABLET 10 INVILIN PLUS SYNOKEM PHARMACEUTICALS LTD 48/100/90/50 MG 10 TABLET ,23, % 0.07% N PENETRAT D 48/90/100 /50MG TABLET 10 PENETRAT D TTK HEALTHCARE LTD 48/90/100 /50MG 10 TABLET ,62,66, % 2.62% Y FINEHEAL D 48/100/90/50 MG TABLET 10 FINEHEAL D UNICHEM LABORATORIES LTD 48/100/90/50 MG 10 TABLET ,76, % 1.19% Y ALANZ D 48/100/90/50 MG TABLET 10 ALANZ D WALLACE PHARMACEUTICALS LTD. 48/100/90/50 MG 10 TABLET ,37,89, % 2.22% Y TIBROLIN D 48/100/90/50 MG TABLET 10 TIBROLIN D ZUVENTUS HEALTHCARE LTD 48/100/90/50 MG 10 TABLET ,97, % 0.69% N Rs. Per Tablet Worked out Retail Price Claimed Retail Price Already notified Retail Price (with 10% increase p.a.) Unit (Rs.) Considered Proposed Retail Price 14.44

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33 Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above

More information

Minimumum Price (Rs.) 6.93 Maximum Price (Rs.) Average of all considered (Rs.) 8.97 Retail Price (Rs.) 10.41

Minimumum Price (Rs.) 6.93 Maximum Price (Rs.) Average of all considered (Rs.) 8.97 Retail Price (Rs.) 10.41 S. No. Computataion of Retail Price based on May, 2016 Data under Para 4 of DPCO 2013 ASPIRIN 75mg + ROSUVASTATIN 10mg + CLOPIDOGREL 75mg Tablet of M/s Safetab Life Science/M/s Intas Pharmaceuticals Ltd.

More information

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No. Number of Companies consisting of Market Share of 1% & Above 2 3.1 Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) 152.69 Sum of PTR per unit considered

More information

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority

More information

What s New

What s New What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related

More information

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application

More information

New Delhi, the 18 th December, 2017 ORDER

New Delhi, the 18 th December, 2017 ORDER (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority

More information

RESULTS AND DISCUSSION

RESULTS AND DISCUSSION RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS

More information

TODAY LETTER DATED

TODAY LETTER DATED TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY

More information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20) (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL

More information

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,

NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA 1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt:21.11.2013 7,98,217.00 2 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt:21.11.2013 15,10,268.00 3 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg)

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC

More information

Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18

Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18 PharmaTrac Overview MAY 18 8434 8956 9655 10422 8112 8917 9549 8258 8921 9406 8668 9630 9381 8662 8373 8999 9013 9796 10413 8742 9315 10050 8458 9180 8601 9092 9767 8364 9145 10583 10173 10387 10217 10476

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY

More information

PROVISIONAL RATE LIST FOR NIT 120 (Pharma)

PROVISIONAL RATE LIST FOR NIT 120 (Pharma) all 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 L1 CIRON DRUGS AND PHARMACEUTICALS PVT LTD 259.0004 259.0004 L2 ABBOTT HEALTHCARE PRIVATE LIMITED 386.66 405.993 2 Adrenochrome Monosemicarbazone

More information

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38 CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 19.06.2015 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI-400 709 2. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT.,

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

Medicines availability short-term supply issues Last updated 01/05/18

Medicines availability short-term supply issues Last updated 01/05/18 Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is

More information

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets

Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable

More information

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

BRIC DIABETES DRUGS MARKET

BRIC DIABETES DRUGS MARKET BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY

More information

Information for Vermont Prescribers of Prescription Drugs Long Form

Information for Vermont Prescribers of Prescription Drugs Long Form Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made

More information

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW... CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00

More information

STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, Pack Size. Vial.

STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, Pack Size. Vial. 1 STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, 2001 Agenda Item No. Company Name/ Formulation Name/Composition Pack Size Existing Price RP

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.

More information

+91-8048607449 Neuracle Lifesciences Private Limited http://www.neuraclelifesciences.com/ We are a leading organization engrossed in trading and wholesaling an effective array of Pharmaceutical Medicines.

More information

Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US)

Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US) Anti Diabetic Gliclazide 30/60 mg ER Tablets Diamicron Gliclazide MR Tablets 60 mg (Servier, France) Tajikistan (Under registration), Vietnam, Uzbekistan US (Filed 2010) US (2013) India (2006), Vietnam

More information

Rezicure Pharmaceuticals

Rezicure Pharmaceuticals +91-8071806292 Rezicure Pharmaceuticals https://www.indiamart.com/rezicurepharmaceuticals/ We are a well known trader and supplier of capsules, injections, syrups, ayurvedic medicines, dry syrups and many

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE

More information

NIT 97 - APPROVED DRUG LIST

NIT 97 - APPROVED DRUG LIST 1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin

More information

Minimum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Ceiling Price (Rs.)

Minimum Price (Rs.) Maximum Price (Rs.) Average of all considered (Rs.) Ceiling Price (Rs.) Computation of Ceiling based on Aug-2015 Data under Para 4 of DPCO 2013 8.1.34 Temozolomide 250mg Tabs Per Tablet Number of Companies consisting of Market Share of 1% & Above 2 Sum of MAT value considered

More information

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE 10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting

More information

List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities)

List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) Edition: Version 11-19th of July 2018 List of A & B Products List Of Antihepatitis Pharmaceutical Products (included to support Global Fund Policy for Co-Infections and Co-Morbidities) As from the version

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public

More information

Provisional L1 rate of Non SSI and SSI tenderers for the Speciality drugs for the year

Provisional L1 rate of Non SSI and SSI tenderers for the Speciality drugs for the year Provisional L1 rate of Non SSI and SSI tenderers for the Speciality drugs for the year 2011-12 Sl. 1 G3 Aceclofenac Tab. - 100mg 10 X 10 16.71 Salus Pharmaceuticals 17.91 Rikenbik Pharma (SSI tenderer)

More information

Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml

Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml : I approve the minutes of 32 nd SEC (Antimicrobial, Antiviral, Antiparasitic and Antifungal) held on 11.04.2017 at CDSCO HQ New Delhi and recommended the following: Agend New Drugs Division 1 12-34/12-DC

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406

More information

Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)

Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets) Information for Vermont Prescribers of Prescription Drugs Lunesta (eszopiclone tablets) This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.

More information

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey

More information

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution

More information

PRODUCTS ARE MANUFACTURED BY WHO GMP CERTIFIED PLANTS. PRODUCTS ARE APPROVED BY D.C.G.I.

PRODUCTS ARE MANUFACTURED BY WHO GMP CERTIFIED PLANTS. PRODUCTS ARE APPROVED BY D.C.G.I. OLENS HEALTH CARE PVT. LTD SHOP NO: 20, 2 nd FLOOR, OLD ROPAR ROAD NEAR SAMADHI GATE, MOTOR MARKET MANIMAJRA, CHANDIGARH-160101, CONTACT NO: +919466093266, +918558992442 E-MAIL: olens.healthcare@gmail.com

More information

Approved L1 rates and tenderers for 162 Speciality drugs for the year

Approved L1 rates and tenderers for 162 Speciality drugs for the year Approved L1 rates and tenderers for 162 Speciality drugs for the year 2011-2012 Sl. Name of the 1 G3 2 G6 3 G8 Aceclofenac Tab. - Acyclovir Inj., USP - Adefovir Dipivoxil Tab. - 10mg 10 X 10 4899800 Vial

More information

LIST OF FORMULATION PRODUCTS. Ferrocid Transule Capsule. Blended Pellets of Carbonyl Iron, Folic Acid & Zinc. Nature Biochem

LIST OF FORMULATION PRODUCTS. Ferrocid Transule Capsule. Blended Pellets of Carbonyl Iron, Folic Acid & Zinc. Nature Biochem LIST OF FORMULATION PRODUCTS Haematinics Ferrocid Transule Capsule Dried Ferrous Sulphate B.P. 1 Folic Acid B.P. 0.5 mg Eleron-F Dried Ferrous Sulphate I.P. 1 5 mg Cyanocobalamin I.P. 15 mcg Zinc Sulphate

More information

List of Ordinary Members as on NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT

List of Ordinary Members as on NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT Sl No NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT MICROCELL INDUSTRIES 5 ADLIFE HEALTHCARE PVT. LTD. 6 AKUMS DRUGS & PHARMACEUTICALS LTD 7 ALCON

More information

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:- Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet

More information

Vol. II, Issue I January S&A PHARMA NEWSLETTER Vol. I, Issue I

Vol. II, Issue I January S&A PHARMA NEWSLETTER Vol. I, Issue I Vol. II, Issue I January 2018 S&A PHARMA NEWSLETTER Vol. I, Issue I EDITORIAL Manoj K. Singh Founding Partner The globalization of Healthcare offers a certain degree of exposure of foreign services, ideas,

More information

NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd.

NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd. S C I Total 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 223.33 6 6 26.7996 250.1296 2 120016 Amitriptyle Tab. IP - 25 mg 10X10 4,120 Micron Pharmaceuticals 27.9 12 3.348 31.248 3 120030

More information

Paediatric ARV Procurement Working Group Progress Review at 31 December 2015

Paediatric ARV Procurement Working Group Progress Review at 31 December 2015 Paediatric ARV Procurement Working Group Progress Review at 31 December 2015 Version 4 March 2015 Updated with complete 2015 data from version presented at the January 27 2016 PAPWG meeting PAPWG Reporting

More information

ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन

ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन ड प स ओ 2013 क प र 4 क तहत, अग त 2015 क आ कड़ क आध रत, म य क स गणन Number of Companies consisting of Market Share of 1% & Above 10 8.4.13 ONDANSETRON 4 MG Tablet Per Tablet Sum of value considered for price

More information

https://www.indiamart.com/medisoftpharma/

https://www.indiamart.com/medisoftpharma/ +91-8048558363 Medi Soft Pharma https://www.indiamart.com/medisoftpharma/ Medi Soft Pharma is a leading Trader and Supplier of Soft Gelatin Capsules, Pharmaceutical Tablets, Pharmaceutical Capsules, Cream

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 28 April 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, d 3 November

More information

Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/ , Dt

Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/ , Dt Statement showing the Item wise BFC Approved list for TNo.2/TSMSIDC/Medicines/2016 18, Dt.24.05.2016 Sl. No Code Group Item Name Firm Name Unit L1 Rate 1 2193 EML Aceclofenac 100mg Tab Deepin Pharmaceuticals

More information

CONTRACT UPDATE July 20, 2012

CONTRACT UPDATE July 20, 2012 CONTRACT UP July 20, 2012 ADDS AMPHETAMINE SALT MIX ER CAPSULE 10MG 100 002-3059-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER CAPSULE 20MG 100 002-3060-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

Patel Krunal M et al. IRJP 2 (2)

Patel Krunal M et al. IRJP 2 (2) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 223 87 Available online http://www.irjponline.com Research Article DESIGN DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE TABLET OF MONTELUKAST SODIUM BY

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

Product Name Composition packing

Product Name Composition packing Product Name Composition packing Bestnac Gel 30gm BIOCLIN MOUTHWASH 150ML BIOCLIN SG Diclofenac Diethylamine BP 1.16% w/w (equivalent to Diclofenac sodium 1.0% w/w, Linseed Oil BP 3% w/w, Menthol IP 5%

More information

+91-8071676405 Geneva Biocare http://www.genevabiocare.com/ We are well-known in the industry as one of the leading suppliers, traders and distributors of Pharmaceutical Medicines. These medicines are

More information

Free Trial Future Generics Database

Free Trial Future Generics Database API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide

More information

Sitnez Biocare (p) Ltd.

Sitnez Biocare (p) Ltd. +91-8048745397 Sitnez Biocare (p) Ltd. https://www.sitnezbiocare.com/ We are considered in the market to be one of the leading manufacturers, wholesalers, traders and suppliers of this highly commendable

More information

https://www.indiamart.com/cureworld-pharmaceutical/

https://www.indiamart.com/cureworld-pharmaceutical/ +91-8071677510 Cure World Pharmaceutical https://www.indiamart.com/cureworld-pharmaceutical/ We are one of the leading Manufacturer and Trader of an excellent quality Pharmaceutical Tablet, Pharmaceutical

More information

RECALL NOTICES 2013 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS

RECALL NOTICES 2013 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS RECALL NOTICES 2013 PLEASE CHECK YOUR RECALL LETTER TO VERIFY PRODUCT NDC LOT NUMBERS Dec 13, 2013 DR. Reddy recalls to the RETAIL Level Metoprolol Succinate ER Tablets 50mg 100 55111-0467-01 C207416 C207420

More information

Indian pharma market Monthly performance tracker

Indian pharma market Monthly performance tracker Sector Update 15 January Healthcare 2015 Sector Update Healthcare Indian pharma market Monthly performance tracker Sustained growth recovery, expect momentum to pick up Performance of top companies: December

More information

Alvizia Healthcare Private Limited

Alvizia Healthcare Private Limited +91-8048413356 Alvizia Healthcare Private Limited https://www.alviziahealthcare.net/ We are one of the leading manufacturers, wholesaler and traders of the Pharmaceutical Products. Owing to their rich

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN

More information

AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF

AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF AZITHROMYCIN 250 MG TREATMENT FOR TOOTHACHE PAIN RELIEF Azithromycin 250 Mg Treatment For Toothache Pain Relief Seeing azithromycin 250 mg Azithromycin tablets ip 500 mg for acne Does azithromycin affect

More information

Enforcement Report - Week of July 19, 2017

Enforcement Report - Week of July 19, 2017 Enforcement Report - Week of July 19, 2017 Class I Event 77055 04/18/2017 Press Release Organic Herbal Supply 8303 Sierra College Blvd Ste 128 Roseville CA United States Nationwide via internet UPROAR

More information

CONTRACT UPDATE June 15, 2012

CONTRACT UPDATE June 15, 2012 CONTRACT UP June 15, 2012 ADDS HYDRALAZINE INJECTION 20MG/ML 1MLX25 17478-0934-15 $143.03 AKORN 06-15-2012 12-31-2013 178739 10106085 ADDS BENZONATATE CAPSULE 100MG 100 65162-0536-10 $9.95 AMNEAL PHARMACEUTICALS

More information